Free Republic 4th Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $6,654
8%  
Woo hoo!! And our first 8% is in!! Thank you all very much!! God bless.

Keyword: antibodytreatment

Brevity: Headers | « Text »
  • Across The State Of Florida, There Are 14 Monoclonal Antibody Treatment Sites Set Up To Serve COVID-19 Positive Floridians—With More To Come

    08/22/2021 2:34:18 PM PDT · by Enlightened1 · 31 replies
    Twitter ^ | 08/22/21 | Governor Ron DeSantis
    Across the state of Florida, there are 14monoclonal antibody treatment sites set up toserve COVID-19 positive Floridians—with more tocome. - Governor Ron DeSantis For more information, visit:floridahealthcovid19.gov
  • Antibody treatment could decrease COVID-19 hospitalizations by 80%, researcher says

    08/15/2021 5:16:22 PM PDT · by BenLurkin · 17 replies
    KVUE ^ | August 14, 2021 | Molly Oak
    Neutralizing monoclonal antibodies are a game-changer in fighting this disease, according to the doctor. Prior to the treatment's availability, if someone tested positive for COVID-19 but wasn’t severe enough to be hospitalized, that person then isolated at home. "Now we can say we actually have something that can decrease your risk of hospitalization and improve your chances of survival if you have features that place you at risk for progressing on to more advanced forms of COVID-19," said Dr. Robert Gottlieb with the Baylor Scott & White Research Institute. This comes as hospitals and ICUs are facing another surge, with...
  • BREAKING: FDA Approves Emergency Use Authorization for Regeneron Antibody Treatment for Covid-19

    11/21/2020 7:27:51 PM PST · by SeekAndFind · 9 replies
    Townhall ^ | 11/21/2020 | Beth Baumann
    The Federal Drug Administration Saturday night approved an Emergency Use Authorization for an antibody treatment President Donald Trump received shortly after being diagnosed with the Wuhan coronavirus. The manufacturer, Regeneron, received the green light for their cocktail of two antibodies – or casirivimab and imdevimab – that appear to be effective for those with mild to moderate coronavirus. The two antibodies, referred to as monoclonal antibodies, are created in a lab and mimic the human body's natural immune system. When administered the cocktail prevents the virus from attaching to human cells. In order to receive the treatment, a patient must...